Share This

Public company info - Simcere Pharmaceutical Group Limited , 02096.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Simcere Pharmaceutical Group Limited, 02096.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12
Net Cash Flow from Operating Activities 1,347,616 -187,270 251,399 1,037,660 930,500 1,062,550
Net Cash Flow from Return on Investments & Servicing of Finance -154,742 -146,263 -51,048 -949,037 -565,192 -40,700
　Interest Received 70,609 26,449 26,118 109,929 22,984 10,839
　Interest Paid -29,983 -70,848 -141,178 -148,313 -39,120 -51,539
　Dividend Received 195,928 289,432 64,012 1,401 0 0
　Dividend Paid -391,296 -391,296 0 -912,054 -549,056 0
　Others 0 0 0 0 0 0
Taxes (Paid) / Refunded 7,096 -14,700 -154,668 -264,857 -154,683 -123,474
Net Cash Flow from Investing Activities -198,231 -751,384 438,953 -704,258 -495,385 -519,229
　Additions to Fixed Assets -342,815 -209,488 -352,841 -507,658 -335,216 -292,200
　Disposal of Fixed Assets 273 5,906 936 3,197 357 850
　Increase in Investments -301,106 -522,377 -102,013 -1,410,055 -896,712 -1,407,764
　Decrease in Investments 124,287 548,823 882,934 974,706 1,154,026 804,613
　Net Cash Flow with Related Parties -16,027 0 0 -129,821 58,252 33,417
　Others 337,157 -574,248 9,937 365,373 -476,092 341,855
Net Cash Flow before Financing Activities 1,001,739 -1,099,617 484,636 -880,492 -284,760 379,147
Net Cash Flow from Financing Activities -332,402 -1,162,387 2,494,800 47,417 899,461 -295,778
　New Loans 916,932 1,027,150 2,056,618 2,605,640 1,646,831 774,459
　Loans Repayment -1,233,307 -2,505,137 -1,826,850 -1,917,712 -771,468 -851,156
　Fixed Income/Debt Instruments 0 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0
　Equity Financing 0 0 3,002,661 0 0 0
　Net Cash Flow with Related Parties -16,027 0 0 -129,821 58,252 33,417
　Others 0 315,600 -737,629 -510,690 -34,154 -252,498
Increase(Decrease) in Cash & Cash Equivalents 669,337 -2,262,004 2,979,436 -833,075 614,701 83,369
Cash & Cash Equivalents at Beginning of Year 973,139 3,270,241 354,804 1,187,647 572,584 489,333
Net Cash Flow due to Change in Exchange Rate/Others 15,124 -35,098 -63,999 232 362 -118
Cash & Cash Equivalents at End of Year 1,657,600 973,139 3,270,241 354,804 1,187,647 572,584
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 0 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.